Capital Flow Monitor · Sponsors · CIK 1947742
Avenzo Therapeutics, Inc.
12707 High Bluff Drive, Suite 200, SAN DIEGO, CA, 92130 · (858) 239-2944
Biotechnology · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$75.0M
Sold
$47.2M
% sold
63.0%
Investors
20
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-05 | D ·current | 506(b) | $75.0M | $47.2M | 63.0% | 20 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Athena Countouriotis — Executive Officer / Director, San Diego, CA
- Brian Sun — Executive Officer, San Diego, CA
- Mohammad Hirmand — Executive Officer, San Diego, CA
-
Simeon George — Director, San Diego, CA
3 other raises
- SR One Capital Fund III, LP $247.3M of $600.0M · 41.2%
- Rezo Therapeutics, Inc. $68.1M of $80.1M · 84.9%
- SR One Co-Invest XIII, LLC $0 of —
-
Carl Gordon — Director, San Diego, CA
2 other raises
- Odyssey Therapeutics, Inc. $214.0M of $214.0M · 100.0%
- Star Therapeutics LLC $125.0M of $125.0M · 100.0%
- Jakob Dupont, M.D., M.A. — Director, San Diego, CA
- Paolo Tombesi — Executive Officer, San Diego, CA
- Scott Lipman — Executive Officer, San Diego, CA
- Judith Li — Director, San Diego, CA
- Garry Nicholson — Director, San Diego, CA
- Patrick Machado — Director, San Diego, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.